Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Rigaku Concludes Successful 3rd European SmartLab Workshop in Karlsruhe
Thursday, August 14, 2014
Workshop focused on application and operation of the SmartLab Intelligent X-ray diffraction system.

Rigaku Launches the XtaLAB PRO Series
Wednesday, August 06, 2014
Single crystal X-ray diffraction HPAD-based systems.

Diamond Light Source Purchases Multiple Electron Microscopes from FEI
Thursday, June 19, 2014
The U.K.’s national synchrotron now has a complete cryo-EM workflow for integrative structural biology to explore essential biological questions at the atomic and molecular scale.

Rigaku Launches the SmartLab 3 System
Tuesday, June 17, 2014
A multipurpose X-ray diffractometer with built-in intelligent guidance.

Rigaku Introduces BioSAXS™-2000 System
Tuesday, May 27, 2014
Brings a beamline experience to home lab SAXS experiments.

A New Tool for Pharmaceutical Companies Technology Transfer from Cornell University
Friday, March 21, 2014
High pressure cryo-cooler for X-ray crystallography from ADC.

New Chilling Incubators with 100 Liter Capacity
Thursday, March 06, 2014
Vibration free incubators are ideal for protein crystallography.

Rigaku Introduces Newest Instruments at Pittcon 2014
Wednesday, February 26, 2014
Company exhibits its benchtop lines of XRD and XRF instrumentation at Booth #2355.

Enhanced Crystallization Control Improves Polymorph Screening
Friday, February 07, 2014
eXalt - An exciting new non-destructive evaporation technology.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 233
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv